BHWM
JAZZ icon

Beaird Harris Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Beaird Harris Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123 Hold
1
– – ﹤0.01% 678
2026
Q1 		$97 Hold
1
– – ﹤0.01% 659
2025
Q4 		$87 Hold
1
– – ﹤0.01% 684
2025
Q3 		$68 Buy
+1
New +$120 ﹤0.01% 712
2023
Q1 		– Sell
-105
Closed -$16.7K – 605
2022
Q4 		$16.7K Buy
+105
New +$15.4K ﹤0.01% 277

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Beaird Harris Wealth Management's JAZZ Position: Q2 2026 in Review

Beaird Harris Wealth Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 1 share worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #678.

Beaird Harris Wealth Management first reported a position in JAZZ in Q4 2022 and has held it in 5 quarters since. The position peaked at $16.7K in Q4 2022. 72 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Beaird Harris Wealth Management held 1 share of Jazz Pharmaceuticals worth $123 as of Q2 2026.
  • Beaird Harris Wealth Management left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #678 holding.
  • Beaird Harris Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Beaird Harris Wealth Management's Jazz Pharmaceuticals position peaked at $16.7K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.